This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Walgreens Boots (WBA) Down 2.4% Since Last Earnings Report
by Zacks Equity Research
Walgreens Boots (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Are Walgreens and CVS Shares Surging Today?
by Ryan McQueeney
Shares of several major pharmaceutical retailers--including Walgreens (WBA) and CVS Health (CVS)--surged in afternoon trading Monday after reports emerged that e-commerce behemoth Amazon (AMZN) has shelved its plan to sell prescription drugs to doctors and hospitals.
Bear of the Day: Signet Jewelers Limited (SIG)
by David Borun
Retail Jewelry Stores are Badly Beaten by the Trend Toward Online Sales
The Zacks Analyst Blog Highlights: Mastercard, Petrobras, Walgreens Boots Alliance, Microchip and Carnival
by Tirthankar Chakraborty
The Zacks Analyst Blog Highlights: Mastercard, Petrobras, Walgreens Boots Alliance, Microchip and Carnival
Top Stock Reports for Mastercard, Petrobras & Walgreens Boots Alliance
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Petrobras (PBR) and Walgreens Boots Alliance (WBA).
Company News For Mar 29, 2018
by Zacks Equity Research
Companies in the news are: LULU,RH,WBA,FB
Walgreens Boots (WBA) Tops Q2 Earnings, Revenues Estimates
by Zacks Equity Research
Walgreens Boots (WBA) rides high in Q2 on strength in Retail Pharmacy USA division and Pharmaceutical Wholesale division.
Should You Buy Walgreens Boots (WBA) Ahead of Earnings?
by Zacks Equity Research
Walgreens Boots (WBA) witnesses improvement in sales at the Retail Pharmacy International segment.
LabCorp Forms Lab-Alliance With Kentucky-Based Health Firm
by Zacks Equity Research
The multi-year, comprehensive laboratory deal to help LabCorp (LH) provide high-quality, high-value and standardized laboratory diagnostics for Appalachian Regional Healthcare.
Should Value Investors Pick Walgreens Boots Alliance (WBA) Stock?
by Zacks Equity Research
Is Walgreens Boots Alliance (WBA) a great pick from the value investor's perspective right now? Read on to know more.
Express Scripts, Walgreens Tie Up to Cut Specialty Drug Price
by Zacks Equity Research
Express Scripts (ESRX) expands group purchasing effort with Walgreens Boots Alliance to simplify supply chains and make specialty drugs affordable.
Rite Aid (RAD) on Track with Asset Sale: Is it Aiding Stock?
by Zacks Equity Research
Rite Aid Corporation (RAD) is on track with the process of transferring stores and related assets to Walgreens under its amended and restated asset purchase agreement.
Rite Aid (RAD) Soars Too High Too Fast: Is This Justified?
by Zacks Equity Research
Rite Aid Corporation (RAD) stock seems to have gained solid momentum following the recent sale of stores to Walgreens. However, the company has been facing issues with dismal sales, heavy debt burden and strained margins.
Top Stock Reports for PepsiCo, Walgreens Boots & EOG Resources
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including PepsiCo (PEP), Walgreens Boots (WBA) and EOG Resources (EOG).
Penumbra (PEN) Forms JV on Virtual Reality in Health Space
by Zacks Equity Research
Penumbra's (PEN) joint venture with Sixense Enterprises indicates formation of a leading digital health platform in the field of virtual reality technology.
ADP ADP Private Sector Payroll Read For December At 250K
by Zacks Equity Research
ADP ADP Private Sector Payroll Read For December At 250K
ADP Brings 250K New Jobs, Better than Expected
by Mark Vickery
Private-sector employment grew bigger than expected in December, with strong holiday sales numbers from key big-box retailers, to boot.
Walgreens Boots (WBA) Tops Q1 Earnings, Revenues Estimates
by Zacks Equity Research
Walgreens Boots (WBA) rides high on balanced growth across all business segments in Q1.
Rite Aid (RAD) Q3 Earnings Beat, Stores Transfer on Track
by Zacks Equity Research
Rite Aid Corporation (RAD) reported third-quarter fiscal 2018 results, which marked a considerable improvement from the company's recent trend. Further, it continues to transfer stores to Walgreens.
Can Constellation Brands (STZ) Retain Earnings Trend in Q3?
by Zacks Equity Research
Constellation Brands Inc. (STZ) is scheduled to report third-quarter fiscal 2018 results on Jan 5. Constellation Brands has been on a roll owing to strong brand portfolio, strategic initiatives and robust quarterly results.
Is a Beat in Store for Walgreens Boots (WBA) in Q1 Earnings?
by Zacks Equity Research
Walgreens Boots' (WBA) Retail Pharmacy USA division continues to witness comparable prescription growth as well as a robust retail prescription market.
Top Research Daily for Chevron, United Technologies & Charter Communications
by Swarup Gupta
Today's Research Daily features new research reports on 16 major stocks, including Chevron (CVX), United Technologies (UTX) and Charter Communications (CHTR).
AmerisourceBergen Banks on Strategic Deals, Competition Rife
by Zacks Equity Research
AmerisourceBergen (ABC) enters a strategic agreement with Walgreen Boots Alliance.
Will Margin Pressure Hurt Finish Line's (FINL) Q3 Earnings?
by Zacks Equity Research
The Finish Line, Inc. (FINL) is slated to release third-quarter fiscal 2018 results on Dec 21. The company is not immune to the intense promotions in the athletic space along with the shift of most retailers to digital and differentiated retailing.
Will NIKE (NKE) Crush Near-Term Hurdles to Beat Q2 Earnings?
by Zacks Equity Research
We expect NIKE Inc. (NKE) to beat expectations when it reports second-quarter fiscal 2018 results on Dec 21. NIKE's robust growth and innovation efforts have been reflected in its robust earnings surprise trend.